FBLG
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- FibroBiologics released the third batch of CYWC628 drug product for its Phase 1/2 diabetic foot ulcer clinical trialAug 27, 2026
- FibroBiologics announced acceptance of an Australian patent covering cannabidiol as an adjuvant therapy for degenerative disc diseaseAug 20, 2026
- FibroBiologics received a U.S. patent covering the use of fibroblasts to improve the survival and function of transplanted insulin-producing isletsAug 11, 2026
- FibroBiologics received a European patent covering gene therapy for cartilage regenerationAug 6, 2026
- FibroBiologics received a notice of allowance for a U.S. patent covering topical fibroblast spheroid therapy for wound healingJun 22, 2026